| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $297.2M | +11.6% |
| Cost of Revenue | $100.1M | +19.2% |
| Gross Profit | $197.1M | +8.1% |
| R&D Expense | $9.6M | +4.4% |
| SG&A Expense | $220.8M | +11.5% |
| Operating Income | -$32.7M | +5.1% |
| Pre-tax Income | -$51.0M | -2.4% |
| Income Tax | $677K | +2.0% |
| Net Income | -$51.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.8M | -38.1% |
| Accounts Receivable | $54.7M | +14.7% |
| Inventory | $27.0M | +121.8% |
| Current Assets | $142.9M | -5.6% |
| Total Assets | $225.9M | -2.9% |
| Current Liabilities | $75.3M | +19.6% |
| Long-term Debt | $146.1M | +20.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.3M | -134.8% |
| Capital Expenditures | $3.4M | +133.8% |
| Investing Cash Flow | -$8.5M | -75.2% |
| Financing Cash Flow | $17.3M | -63.4% |
| Free Cash Flow | -$45.7M | -134.7% |
| -2.4% |
| EPS (Basic) | -$0.80 | +1.2% |
| EPS (Diluted) | -$0.80 | +1.2% |
| Total Liabilities |
| $249.0M |
| +9.7% |
| Stockholders' Equity | -$23.1M | -518.4% |